These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25647400)

  • 21. Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy.
    Zhai YL; Zhu L; Shi SF; Liu LJ; Lv JC; Zhang H
    Medicine (Baltimore); 2016 Mar; 95(11):e3099. PubMed ID: 26986150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy.
    Liu Y; Liu X; Jia J; Zheng J; Yan T
    J Transl Med; 2019 Sep; 17(1):320. PubMed ID: 31547815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of glycogenes in tonsillar B lymphocytes in association with proteinuria and renal dysfunction in IgA nephropathy.
    Inoue T; Sugiyama H; Hiki Y; Takiue K; Morinaga H; Kitagawa M; Maeshima Y; Fukushima K; Nishizaki K; Akagi H; Narimatsu Y; Narimatsu H; Makino H
    Clin Immunol; 2010 Sep; 136(3):447-55. PubMed ID: 20538527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Progression in the mechanism of the Cosmc in IgA nephropathy].
    Zhou N; Shen Y
    Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):549-51. PubMed ID: 24267143
    [No Abstract]   [Full Text] [Related]  

  • 25. C1GALT1 expression is associated with galactosylation of IgA1 in peripheral B lymphocyte in immunoglobulin a nephropathy.
    Xing Y; Li L; Zhang Y; Wang F; He D; Liu Y; Jia J; Yan T; Lin S
    BMC Nephrol; 2020 Jan; 21(1):18. PubMed ID: 31941451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes E3 ubiquitin protein ligase 1 gene mRNA expression correlated with IgA1 glycosylation in patients with IgA nephropathy.
    Liu Y; Zheng J; Jia J; Li H; Hu S; Lin Y; Yan T
    Ren Fail; 2019 Nov; 41(1):370-376. PubMed ID: 31057023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
    Xu LX; Zhao MH
    Kidney Int; 2005 Jul; 68(1):167-72. PubMed ID: 15954905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of adiponectin by aberrantly glycosylated IgA1 in glomerular mesangial cells in vitro and in vivo.
    Inoue T; Sugiyama H; Kitagawa M; Takiue K; Morinaga H; Ogawa A; Kikumoto Y; Kitamura S; Maeshima Y; Makino H
    PLoS One; 2012; 7(3):e33965. PubMed ID: 22457806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CagA, a major virulence factor of Helicobacter pylori, promotes the production and underglycosylation of IgA1 in DAKIKI cells.
    Yang M; Li FG; Xie XS; Wang SQ; Fan JM
    Biochem Biophys Res Commun; 2014 Feb; 444(2):276-81. PubMed ID: 24462875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokines and Production of Aberrantly
    Person T; King RG; Rizk DV; Novak J; Green TJ; Reily C
    J Interferon Cytokine Res; 2022 Jul; 42(7):301-315. PubMed ID: 35793525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy.
    Buck KS; Smith AC; Molyneux K; El-Barbary H; Feehally J; Barratt J
    Kidney Int; 2008 May; 73(10):1128-36. PubMed ID: 18322546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgA1 glycosylation in IgA nephropathy: as sweet as it can be.
    Eijgenraam JW; van Kooten C
    Kidney Int; 2008 May; 73(10):1106-8. PubMed ID: 18449177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y; Zhao MH; Zhang YK; Li XM; Wang HY
    Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LPS/TLR4 Pathway Regulates IgA1 Secretion to Induce IgA Nephropathy.
    He H; Shen M; Tang Y; Sun W; Xu X
    Altern Ther Health Med; 2024 Jan; 30(1):419-425. PubMed ID: 37820669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrantly methylated DNA regions lead to low activation of CD4+ T-cells in IgA nephropathy.
    Sallustio F; Serino G; Cox SN; Dalla Gassa A; Curci C; De Palma G; Banelli B; Zaza G; Romani M; Schena FP
    Clin Sci (Lond); 2016 May; 130(9):733-46. PubMed ID: 26846681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients.
    Kosztyu P; Hill M; Jemelkova J; Czernekova L; Kafkova LR; Hruby M; Matousovic K; Vondrak K; Zadrazil J; Sterzl I; Mestecky J; Raska M
    Kidney Blood Press Res; 2018; 43(2):350-359. PubMed ID: 29529610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paradigm shift in activity assessment of IgA nephropathy - optimizing the next generation of diagnostic and therapeutic maneuvers via glycan targeting.
    Suzuki Y; Suzuki H; Yasutake J; Tomino Y
    Expert Opin Biol Ther; 2015 Apr; 15(4):583-93. PubMed ID: 25604055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.
    Reily C; Ueda H; Huang ZQ; Mestecky J; Julian BA; Willey CD; Novak J
    J Immunol Res; 2014; 2014():197548. PubMed ID: 25152896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ST6Gal1 is up-regulated and associated with aberrant IgA1 glycosylation in IgA nephropathy: An integrated analysis of the transcriptome.
    Liu Y; Wang F; Zhang Y; Jia J; Yan T
    J Cell Mol Med; 2020 Sep; 24(18):10493-10500. PubMed ID: 32677771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of IgG antibody to galactose-deficient IgA1 in children with IgA nephropathy].
    Zhou N; Zhang H; Liu XR; Sun Q; Meng Q; Chen Z; Shen Y
    Zhonghua Er Ke Za Zhi; 2017 Sep; 55(9):663-667. PubMed ID: 28881511
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.